Arkolith/Insider Trading/DNA/Form 4

Coen Steven P.

See remarksGinkgo Bioworks Holdings, Inc. (DNA) · full profile →Form 4 · filed Apr 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2026Sell(S)324$7.95$3K50K
Apr 16, 2026Option exercise(M)587——50K
Apr 16, 2026Option exercise(M)156——51K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 16, 2026Option exercise(M)587——8K
Apr 16, 2026Option exercise(M)156——4K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-026038) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML